Theodore Alan Huizenga - Dec 10, 2024 Form 4 Insider Report for Ultragenyx Pharmaceutical Inc. (RARE)

Role
SVP, Chief Accounting Officer
Signature
/s/ Karah Parschauer, attorney-in-fact
Stock symbol
RARE
Transactions as of
Dec 10, 2024
Transactions value $
$0
Form type
4
Date filed
12/11/2024, 06:47 PM
Previous filing
Sep 18, 2024
Next filing
Mar 4, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RARE Common Stock Gift $0 -648 -1.53% $0.00 41.8K Dec 10, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
F2 Includes 237 shares acquired under the Company's A&R 2014 Employee Stock Purchase Plan on October 31, 2024.